Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alnylam Pharmaceuticals (GB:0HD2)
LSE:0HD2
Alnylam Pharma (0HD2) Ownership - Who Owns Alnylam Pharma?
3 Followers
Alnylam Pharma (0HD2) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
5.44% Other Institutional Investors
94.56% Public Companies and
Individual Investors
The ownership structure of Alnylam Pharma (GB:0HD2) stock is a mix of institutional, retail and individual investors. Approximately 5.44% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 94.56% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 26, 2024 | Yvonne Greenstreet Ceo,director | xxxxxxxxxxxxx | $1917475 |
| Jun 26, 2024 | Pushkal Garg Cmo & Evp Dev & Med Affairs | xxxxxxxxxxxxx | $485773 |
| Jun 26, 2024 | Jeffrey V. Poulton Evp & Cfo | xxxxxxxxxxxxx | $370747 |
| Jun 26, 2024 | Tolga Tanguler Evp & Cco | xxxxxxxxxxxxx | $370747 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $257651 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $305924 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $1234905 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $7909192 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 136 | Insider | ― | 31,780 | |
| 10,256,633 | Insider | ― | 2,396,769,999 | |
| 23,289 | Insider | ― | 5,442,174 | |
| 20,029 | Insider | ― | 4,680,377 | |
| 19,869 | Insider | ― | 4,642,988 | |
| 73,501 | Insider | ― | 17,175,714 | |
| 1,000 | Insider | ― | 233,680 | |
| 8,436 | Insider | ― | 1,971,324 | |
| 8,891 | Insider | ― | 2,077,649 | |
| 3,636 | Insider | ― | 849,660 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 250 | Institution | ― | 58,420 | |
| 149,087 | Institution | ― | 34,838,650 | |
| 180,373 | Institution | ― | 42,149,563 | |
| 9,140 | Institution | ― | 2,135,835 | |
| 51,110 | Institution | ― | 11,943,385 | |
| 297,712 | Institution | ― | 69,569,340 | |
| 16,519 | Institution | ― | 3,860,160 | |
| 12,425 | Institution | ― | 2,903,474 | |
| 23,080 | Institution | ― | 5,393,334 | |
| 9,253 | Institution | ― | 2,162,241 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Alnylam Pharmaceuticals (GB:0HD2)?
According to the latest TipRanks data, approximately 5.44% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 94.56% is held by retail investors.
What percentage of Alnylam Pharmaceuticals (GB:0HD2) stock is held by institutional investors?
According to the latest TipRanks data, approximately 5.44% of Alnylam Pharmaceuticals (GB:0HD2) stock is held by institutional investors.
What percentage of Alnylam Pharmaceuticals (GB:0HD2) stock is held by retail investors?
According to the latest TipRanks data, approximately 94.56% of Alnylam Pharmaceuticals (GB:0HD2) stock is held by retail investors.
Who owns the most shares of Alnylam Pharmaceuticals (GB:0HD2)?
Marsha Fanucci owns the most shares of Alnylam Pharmaceuticals (GB:0HD2).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.